Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 17, 2022
- Revision received April 7, 2022
- Accepted April 11, 2022
- Published online June 22, 2022.
Copyright & Usage
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- 1Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany
- 2Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland
- Correspondence to: Ulrich H. Weidle, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, D-82372 Penzberg, Germany. E-mail weidle49{at}t-online.de
- Correspondence to: Fabian Birzele, Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland. Tel: +41 616889536, e-mail: fabian.birzele{at}roche.com